日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Ex vivo drug response profiling for response and outcome prediction in hematologic malignancies: the prospective non-interventional SMARTrial

体外药物反应分析用于预测血液系统恶性肿瘤的反应和结果:前瞻性非干预性 SMARTrial

Nora Liebers #, Peter-Martin Bruch #, Tobias Terzer, Miguel Hernandez-Hernandez, Nagarajan Paramasivam, Donnacha Fitzgerald, Heidi Altmann, Tobias Roider, Carolin Kolb, Mareike Knoll, Angela Lenze, Uwe Platzbecker, Christoph Röllig, Claudia Baldus, Hubert Serve, Martin Bornhäuser, Daniel Hübschmann,

Targeting Acute Myeloid Leukemia Using the RevCAR Platform: A Programmable, Switchable and Combinatorial Strategy

利用 RevCAR 平台靶向治疗急性髓系白血病:一种可编程、可切换和组合的策略

Enrico Kittel-Boselli, Karla Elizabeth González Soto, Liliana Rodrigues Loureiro, Anja Hoffmann, Ralf Bergmann, Claudia Arndt, Stefanie Koristka, Nicola Mitwasi, Alexandra Kegler, Tabea Bartsch, Nicole Berndt, Heidi Altmann, Frederick Fasslrinner, Martin Bornhäuser, Michael Philipp Bachmann, Anja Fe

Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia

免疫景观预测急性髓系白血病的化疗耐药性和免疫治疗反应

Jayakumar Vadakekolathu, Mark D Minden, Tressa Hood, Sarah E Church, Stephen Reeder, Heidi Altmann, Amy H Sullivan, Elena J Viboch, Tasleema Patel, Narmin Ibrahimova, Sarah E Warren, Andrea Arruda, Yan Liang, Thomas H Smith, Gemma A Foulds, Michael D Bailey, James Gowen-MacDonald, John Muth, Marc Sc